Chelsea Therapeutics International, Ltd.
Overview
Chelsea Therapeutics International, Ltd., acquired by Lundbeck, was a biopharmaceutical company focused on the development of innovative pharmaceutical products for the treatment of rare and difficult-to-treat diseases. The company's portfolio included therapies for conditions such as neurogenic orthostatic hypotension.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Chelsea Therapeutics International, Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Chelsea Therapeutics International, Ltd.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.